iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://dbpedia.org/resource/Andrew_Herxheimer
About: Andrew Herxheimer
An Entity of Type: medician, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Andrew Herxheimer (4 November 1925 – 21 February 2016) was a German-born British clinical pharmacologist. He was "interested in all aspects of providing independent, unbiased, clear and concise information about therapeutic interventions to professionals and the public, and [had] a long experience of observing the pharmaceutical industry at work". He is known for founding Drug and Therapeutics Bulletin, to better educate medical providers on prescription drugs. After retiring from his academic career at London Hospital and Charing Cross in 1991, he continued his career as a consultant for the Cochrane Collaboration with a focus on adverse drug effects, and as an internationalist in patient advocacy and consumer advocacy.

Property Value
dbo:abstract
  • Andrew Herxheimer (* 4. November 1925 in Berlin; † 21. Februar 2016 in London) war ein deutsch-britischer Arzt und klinischer Pharmakologe. Er war Gründer und von 1963 bis 1992 Herausgeber des unabhängigen Drugs and Therapeutics Bulletin. (de)
  • Andrew Herxheimer (4 November 1925 – 21 February 2016) was a German-born British clinical pharmacologist. He was "interested in all aspects of providing independent, unbiased, clear and concise information about therapeutic interventions to professionals and the public, and [had] a long experience of observing the pharmaceutical industry at work". He is known for founding Drug and Therapeutics Bulletin, to better educate medical providers on prescription drugs. After retiring from his academic career at London Hospital and Charing Cross in 1991, he continued his career as a consultant for the Cochrane Collaboration with a focus on adverse drug effects, and as an internationalist in patient advocacy and consumer advocacy. (en)
dbo:birthDate
  • 1925-11-04 (xsd:date)
dbo:deathDate
  • 2016-02-21 (xsd:date)
dbo:institution
dbo:knownFor
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 50187380 (xsd:integer)
dbo:wikiPageLength
  • 10304 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1119891968 (xsd:integer)
dbo:wikiPageWikiLink
dbp:birthDate
  • 1925-11-04 (xsd:date)
dbp:deathDate
  • 2016-02-21 (xsd:date)
dbp:field
dbp:knownFor
  • founded Drug and Therapeutics Bulletin (en)
dbp:name
  • Andrew Herxheimer (en)
dbp:notableWorks
dbp:profession
  • Physician (en)
dbp:specialism
  • patient advocacy and consumer advocacy (en)
dbp:wikiPageUsesTemplate
dbp:workInstitutions
  • London Hospital and Charing Cross (en)
dct:subject
schema:sameAs
rdf:type
rdfs:comment
  • Andrew Herxheimer (* 4. November 1925 in Berlin; † 21. Februar 2016 in London) war ein deutsch-britischer Arzt und klinischer Pharmakologe. Er war Gründer und von 1963 bis 1992 Herausgeber des unabhängigen Drugs and Therapeutics Bulletin. (de)
  • Andrew Herxheimer (4 November 1925 – 21 February 2016) was a German-born British clinical pharmacologist. He was "interested in all aspects of providing independent, unbiased, clear and concise information about therapeutic interventions to professionals and the public, and [had] a long experience of observing the pharmaceutical industry at work". He is known for founding Drug and Therapeutics Bulletin, to better educate medical providers on prescription drugs. After retiring from his academic career at London Hospital and Charing Cross in 1991, he continued his career as a consultant for the Cochrane Collaboration with a focus on adverse drug effects, and as an internationalist in patient advocacy and consumer advocacy. (en)
rdfs:label
  • Andrew Herxheimer (en)
  • Andrew Herxheimer (de)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • Andrew Herxheimer (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License